Soliris

Made by

• Alexion

Active Ingredient

Eculizumab

Prospectus

Approval date

2010/4/16

Treats

• Paroxysmal nocturnal hemoglobinuria
• Neuromyelitis optica, Devic disease
• Myasthenia gravis
• Atypical hemolytic uremic syndrome

Dosages

• SOLIRIS for Intravenous Infusion 300mg - 604716円／瓶